Explorer

DeepMind's CEO On How AI Will Make Drug Discovery Faster Than Ever

Demis Hassabis, the head of Google's DeepMind, believes AI will soon revolutionise medicine, accelerating the drug discovery process from years to a matter of months.

Finding new medicines usually takes many years and often ends in failure. But Demis Hassabis, the Nobel Prize-winning head of Alphabet’s AI arm DeepMind, thinks this can change with artificial intelligence. He said drug discovery may soon take months instead of years. This could mean patients get new treatments faster and at lower costs, as reported by Bloomberg.

Hassabis, who also leads Alphabet’s Isomorphic Labs, said the tools built by DeepMind are now ready to move from research into real medical use.

AI Could Cut Time From Years To Months

Hassabis runs Google DeepMind and also leads Isomorphic Labs, a drug discovery division created in 2021. Since its launch, Isomorphic Labs has signed deals with Eli Lilly & Co. and Novartis AG.

Bloomberg reported that the company is using AlphaFold, an AI tool that predicts protein behaviour, to help design new drugs. Hassabis and fellow scientist John Jumper won the 2024 Nobel Prize in chemistry for their work on this technology.

The company is now developing a more advanced version of AlphaFold that can study more than just protein interactions. Earlier this year, Isomorphic Labs raised $600 million, led by Thrive Capital and is now valued at over $100 billion, according to Hassabis.

The lab is working on treatments for cancer and immune system disorders, with early results showing “good progress.”

First Steps And What’s Next

Even though AI has shown promise in analysing complex molecular data, no AI-designed drug has yet completed a successful clinical trial. Hassabis earlier said clinical testing could begin by the end of this year, but the timeline remains unclear. “It’s a bit early to say,” he admitted.

Rebecca Paul, director of medicinal drug design at Isomorphic Labs, added that AI could eventually turn many cancers into treatable chronic illnesses. While the timing is uncertain, she said the progress so far is encouraging.

About the author Annie Sharma

Annie Sharma is a technology journalist at ABP Live English, focused on breaking down complex tech stories into clear, reader-friendly narratives. Gaining hands-on experience in digital storytelling and news writing with leading publications, Annie believes technology should feel accessible rather than overwhelming, and follows a clear, reader-first approach in her work.

For tips and queries, you can reach out to her at annies@abpnetwork.com.

Read More

Top Headlines

IPL 2026 Day 1 Celebrated By Google With Animated Neon Doodle. Check Out Animated GIF
IPL 2026 Day 1 Celebrated By Google With Animated Neon Doodle. Check Out Animated GIF
Bad Webcam On Your Laptop? Here Is How Your Phone Can Replace It For Free
Bad Webcam On Your Laptop? Here Is How Your Phone Can Replace It For Free
Waiting For iPhone 18 Pro & iPhone 18 Pro Max? Apple May Have One More Surprise Up Its Sleeve
Waiting For iPhone 18 Pro & iPhone 18 Pro Max? Apple May Have One More Surprise Up Its Sleeve
Melania Trump Brought A $25,000 Humanoid Robot To The White House: Here's What It Can Do
Melania Trump Brought A $25,000 Humanoid Robot To The White House: Here's What It Can Do

Videos

Anti-War Wave: Iran Strikes Dimona as Global Protests Surge Against Escalating War
Tactical Shift: Trump Faces Tough Choices as War Pressure Mounts, US Signals Ground Offensive
War Alert: Israel Strikes Tehran as US Deploys USS Tripoli, War Enters Critical Phase
Breaking News: Middle East War Escalates Around Nuclear Targets, Global Concerns Rise
Alliance Strain: US–Israel Rift Debate Grows Amid Claims of Miscalculation in Iran War

Photo Gallery

25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Embed widget